PAP + HPV Co-Testing Increases Cevical Cancer Detection

Article

Recent developments in cervical cancer screening, including the approval of a DNA-based HPV test as a stand-alone method for screening, has stirred debate on whether the Pap test should remain part of frontline cervical cancer screening.

 

PAP + HPV Co-Testing Increases Cevical Cancer Detection



Historically, the Papanicolaou (Pap) test was one of the most powerful weapons primarily responsible for the dramatic reduction in cervical cancer in the twentieth century. By the beginning of the twenty-first century, the combined use of Pap tests and high-risk human papillomavirus virus (HPV) based molecular assays contributed to a steady decline in the incidence of cervical cancer. However, recent developments in cervical cancer screening, including the approval of a DNA-based HPV test as a stand-alone method for screening, has stirred debate on whether the Pap test should remain part of frontline cervical cancer screening.

 

 

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.